Trivedi Malav S, Hodgson Nathaniel W, Walker Stephen J, Trooskens Geert, Nair Vineeth, Deth Richard C
Department of Pharmaceutical Sciences, Nova Southeastern University, Rm # 3103, HPD building, Fort Lauderdale, FL USA.
Department of Molecular and Cellular Biology, Harvard Medical School, Boston, MA USA.
Nutr Metab (Lond). 2015 Dec 9;12:54. doi: 10.1186/s12986-015-0050-1. eCollection 2015.
Casein-free, gluten-free diets have been reported to mitigate some of the inflammatory gastrointestinal and behavioral traits associated with autism, but the mechanism for this palliative effect has not been elucidated. We recently showed that the opioid peptide beta-casomorphin-7, derived from bovine (bBCM7) milk, decreases cysteine uptake, lowers levels of the antioxidant glutathione (GSH) and decreases the methyl donor S-adenosylmethionine (SAM) in both Caco-2 human GI epithelial cells and SH-SY5Y human neuroblastoma cells. While human breast milk can also release a similar peptide (hBCM-7), the bBCM7 and hBCM-7 vary greatly in potency; as the bBCM-7 is highly potent and similar to morphine in it's effects. Since SAM is required for DNA methylation, we wanted to further investigate the epigenetic effects of these food-derived opioid peptides. In the current study the main objective was to characterize functional pathways and key genes responding to DNA methylation effects of food-derived opioid peptides.
SH-SY5Y neuroblastoma cells were treated with 1 μM hBCM7 and bBCM7 and RNA and DNA were isolated after 4 h with or without treatment. Transcriptional changes were assessed using a microarray approach and CpG methylation status was analyzed at 450,000 CpG sites. Functional implications from both endpoints were evaluated via Ingenuity Pathway Analysis 4.0 and KEGG pathway analysis was performed to identify biological interactions between transcripts that were significantly altered at DNA methylation or transcriptional levels (p < 0.05, FDR <0.1).
Here we show that hBCM7 and bBCM7, as well as morphine, cause epigenetic changes affecting gene pathways related to gastrointestinal disease and inflammation. These epigenetic consequences exhibited the same potency order as opiate inhibition of cysteine uptake insofar as hBCM7 was less potent than bBCM7, which was less potent than morphine.
Our findings indicate that epigenetic effects of milk-derived opiate peptides may contribute to GI dysfunction and inflammation in sensitive individuals. While the current study was performed using SH-SY5Y neuronal cellular models, similar actions on other cells types might combine to cause symptoms of intolerance. These actions may provide a potential contributing mechanism for the beneficial effects of a casein-free diet in alleviating gastrointestinal symptoms in neurological conditions including autism and other conditions. Lastly, our study also contributes to the evolving awareness of a "gut-brain connection".
据报道,无酪蛋白、无麸质饮食可减轻一些与自闭症相关的胃肠道炎症和行为特征,但这种缓解作用的机制尚未阐明。我们最近发现,源自牛乳的阿片肽β-酪蛋白吗啡-7(bBCM7)会降低半胱氨酸摄取,降低抗氧化剂谷胱甘肽(GSH)水平,并降低Caco-2人胃肠道上皮细胞和SH-SY5Y人神经母细胞瘤细胞中的甲基供体S-腺苷甲硫氨酸(SAM)。虽然人母乳也能释放一种类似的肽(hBCM-7),但bBCM7和hBCM-7的效力差异很大;因为bBCM-7效力很强,其作用与吗啡相似。由于DNA甲基化需要SAM,我们想进一步研究这些食物来源的阿片肽的表观遗传效应。在本研究中,主要目的是表征对食物来源的阿片肽的DNA甲基化效应作出反应的功能途径和关键基因。
用1μM的hBCM7和bBCM7处理SH-SY5Y神经母细胞瘤细胞,处理4小时后,无论是否处理,均分离RNA和DNA。使用微阵列方法评估转录变化,并在450,000个CpG位点分析CpG甲基化状态。通过Ingenuity Pathway Analysis 4.0评估两个终点的功能影响,并进行KEGG途径分析,以识别在DNA甲基化或转录水平上显著改变的转录本之间的生物学相互作用(p < 0.05,FDR < 0.1)。
我们在此表明,hBCM7、bBCM7以及吗啡都会引起表观遗传变化,影响与胃肠道疾病和炎症相关的基因途径。这些表观遗传后果与阿片类药物抑制半胱氨酸摄取表现出相同的效力顺序,即hBCM7的效力低于bBCM7,而bBCM7的效力低于吗啡。
我们的研究结果表明,源自牛奶的阿片肽的表观遗传效应可能导致敏感个体出现胃肠道功能障碍和炎症。虽然目前的研究是使用SH-SY5Y神经元细胞模型进行的,但对其他细胞类型的类似作用可能共同导致不耐受症状。这些作用可能为无酪蛋白饮食在缓解包括自闭症和其他疾病在内的神经疾病中的胃肠道症状的有益效果提供潜在的作用机制。最后,我们的研究也有助于人们对“肠脑连接”的认识不断发展。